Cargando…
Reappraisal of the role of dolasetron in prevention and treatment of nausea and vomiting associated with surgery or chemotherapy [Erratum]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930224/ https://www.ncbi.nlm.nih.gov/pubmed/27390532 http://dx.doi.org/10.2147/CMAR.S115369 |
Ejemplares similares
-
Reappraisal of the role of dolasetron in prevention and treatment of
nausea and vomiting associated with surgery or chemotherapy
por: Roberts, S Michael, et al.
Publicado: (2012) -
Erratum to: Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study
por: Escobar, Yolanda, et al.
Publicado: (2015) -
Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV)
por: Schwartzberg, Lee, et al.
Publicado: (2013) -
Erratum to: ‘Prophylaxis and management of postoperative nausea and vomiting in enhanced recovery protocols’
por: Gupta, Ruchir, et al.
Publicado: (2016) -
Erratum: Pregnancy complications and birth outcomes among women experiencing nausea only or nausea and vomiting during pregnancy in the Norwegian Mother and Child Cohort Study
por: Chortatos, Arthur, et al.
Publicado: (2015)